July 8 (Reuters) - Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two ...

A diabetes drug was linked to a surprising effect on the risk of dementia.

Health chiefs have been accused of exaggerating the cost of administering breakthrough Alzheimer’s drugs, resulting in their rollout being blocked.

Health chiefs must act now to allow millions of people to benefit from “statins for the brain”, scientists say.

A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new ...

A drug that raises levels of histamine – the chemical that causes allergy symptoms – in the brain boosts our memory by around ...

Neuroscientists from King's College London have developed an approach that targets a key protein to tackle several features of Alzheimer's disease in ...

Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their ...

Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in ...

Beckman Coulter's assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs ...

With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related ...

Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.